Agios Pharmaceuticals

AGIO

66.07

-1.05

-1.6%

After Hours:

66.07

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 66.68
Prev. Close: 67.12
Low/Hi: 65.23 - 67.00
52-Week: 39.24 - 67.74
Volumes
Equity: 245,305
90-Day Avg: 488,831
Option: 41
90-Day Avg: 269
Volatility
Todays Stock Vol: 24.8
20-Day (HV): 33.8
52-Week (HV): 53.5
30-Day IV: 41.8 -0.1
IV Pct Rank: 1% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 3-Nov (Est.)
P/E Ratio:
Market Cap: 3.2 B
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

AGIO Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income -94,428 -66,166 -56,486 -62,834
Change in Working Capital 10,402 -20,436 -6,538 21
Depreciation Amortization Depletion and Accretion 1,504 1,754 1,961 1,640
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 12,187 10,774 9,840 12,143
Total Cash from Operating Activities -58,989 -74,074 -51,223 -49,030
Capital Expenditures -1,035 -293 -1,222 -3,426
Other Investing Cash Flow -274,690 109,845 -76,296 -59,318
Total Cash from Investing Activities -275,725 109,552 -77,518 -62,744
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 272,949 4,146 4,099 163,352
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 204 -100 -106 -124
Total Cash from Financing Activities 273,153 4,046 3,993 163,228
Exchange Rate Effects 0 0 0 0
Net Change in Cash -61,561 39,524 -124,748 51,454
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income -198,471 -117,732 -53,504 -43,569
Change in Working Capital 188,466 4,906 -19,260 -25,589
Depreciation Amortization Depletion and Accretion 6,481 3,881 1,905 1,724
Deferred Taxes 0 0 0 3,842
Other Non-Cash Activities 42,086 31,996 11,506 3,030
Total Cash from Operating Activities 38,562 -76,949 -59,353 -56,400
Capital Expenditures -9,915 -20,164 -2,216 -1,294
Other Investing Cash Flow -109,435 148,473 -331,120 -85,923
Total Cash from Investing Activities -119,350 128,309 -333,336 -87,217
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 170,008 6,580 335,880 126,267
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow -230 -207 -720 -2,387
Total Cash from Financing Activities 169,778 6,373 335,160 123,880
Exchange Rate Effects 0 0 0 0
Net Change in Cash 88,990 57,733 -57,529 -19,737